PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 1,904 Shares

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 1,904 shares of PACS Group stock in a transaction on Thursday, October 29th. The stock was sold at an average price of $50.05, for a total transaction of $95,295.20. Following the sale, the chief executive officer directly owned 54,179,397 shares of the company’s stock, valued at $2,711,678,819.85. This represents a 0.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Wednesday, October 28th, Jason Murray sold 6,899 shares of PACS Group stock. The stock was sold at an average price of $50.10, for a total transaction of $345,639.90.
• On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The shares were sold at an average price of $48.60, for a total value of $3,349,366.20.
• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total value of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total value of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total value of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total value of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The stock was sold at an average price of $47.61, for a total value of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total value of $5,201,354.45.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total value of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The shares were sold at an average price of $42.48, for a total value of $30,458.16.

PACS Group Stock Performance

NYSE:PACS opened at $47.76 on Friday. The business has a 50 day moving average of $44.21 and a 200 day moving average of $39.79. The company has a market capitalization of $7.56 billion, a price-to-earnings ratio of 27.77, a PEG ratio of 1.49 and a beta of -0.08. PACS Group, Inc. has a 1-year low of $10.31 and a 1-year high of $50.38. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.91 and a quick ratio of 0.91.

PACS Group (NYSE:PACS) last issued its earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.09. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. The business had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. On average, sell-side analysts predict that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.

Key Stories Impacting PACS Group

Here are the key news stories impacting PACS Group this week:

• Neutral Sentiment: CEO Jason Murray, Director Mark Hancock, and Chief Accounting Officer Michelle Lewis collectively sold approximately 33,935 shares for about $1.70 million at prices near $50 per share. However, the transactions were executed under pre-arranged 10b5-1 plans, and the executives continue to hold substantial positions. The sales therefore appear more consistent with scheduled diversification or liquidity needs than a clear indication of weakening confidence. Mark Hancock insider-trading filing Jason Murray insider-trading filing Michelle Lewis insider-trading filing
• Negative Sentiment: A shareholder-focused law firm issued an alert encouraging PACS investors to contact the Shareholders Foundation regarding a potential lawsuit. The notice provides no confirmed allegations or details about the case in the supplied report, so the immediate financial impact is uncertain, but litigation-related headlines can create additional volatility and concern around the stock. PACS shareholder lawsuit alert

Hedge Funds Weigh In On PACS Group

A number of large investors have recently bought and sold shares of the stock. Dimensional Fund Advisors LP lifted its position in PACS Group by 370.2% in the first quarter. Dimensional Fund Advisors LP now owns 780,159 shares of the company’s stock valued at $25,051,000 after purchasing an additional 614,250 shares during the last quarter. Bank of New York Mellon Corp purchased a new stake in shares of PACS Group during the second quarter valued at approximately $8,196,000. Principal Financial Group Inc. purchased a new stake in shares of PACS Group during the first quarter valued at approximately $3,171,000. Arrowstreet Capital Limited Partnership grew its holdings in shares of PACS Group by 44.6% in the first quarter. Arrowstreet Capital Limited Partnership now owns 288,718 shares of the company’s stock worth $9,274,000 after purchasing an additional 89,067 shares during the last quarter. Finally, Cantor Fitzgerald Investment Advisors L.P. bought a new position in shares of PACS Group in the third quarter worth approximately $1,920,000.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on PACS. Zacks Research cut shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. Oppenheimer lifted their target price on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a research report on Monday, August 10th. UBS Group boosted their price target on shares of PACS Group from $57.00 to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Royal Bank Of Canada upped their price target on shares of PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. Finally, Weiss Ratings raised PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, PACS Group presently has a consensus rating of “Moderate Buy” and an average price target of $58.80.

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.